Dr. Barr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
Philadelphia, PA 19104Phone+1 215-662-6503Fax+1 301-480-0611
Education & Training
- Children's Hospital of PhiladelphiaPost-Doctoral Fellowship, 1989 - 1992
- University of PennsylvaniaResidency, 1987 - 1992
- Washington University in St. Louis School of MedicineClass of 1987
- Washington University in St. LouisPhD, Molecular Biology, 1982 - 1986
- Williams CollegeBA, Chemistry, Summa Cum Laude, 1976 - 1980
Certifications & Licensure
- PA State Medical License 1989 - 2024
- American Board of Pathology Anatomic Pathology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2001
Publications & Presentations
PubMed
- Novel PAX3::MAML3 Fusion Identified in Alveolar Rhabdomyosarcoma, Using DNA Methylation Profiling to Expand the Genetic Spectrum of "Fusion-Positive" Cases.Josephine K Dermawan, Faizan Malik, John M Gross, Ezra Baraban, Christine Pratilas
Modern Pathology. 2024-11-01 - 4 citationsThe PAX Genes: Roles in Development, Cancer, and Other Diseases.Taryn Shaw, Frederic G Barr, Aykut Üren
Cancers. 2024-02-29 - 1 citationsPrevalence of alternative lengthening of telomeres in pediatric sarcomas determined by the telomeric DNA C-circle assay.Trevor A Burrow, Balakrishna Koneru, Shawn J Macha, Wenyue Sun, Frederic G Barr
Frontiers in Oncology. 2024-01-01
Grant Support
- DNA Methylation-Based Assays For Detecting Disease Spread In RhabdomyosarcomaNational Cancer Institute2010
- COG Studies Of Gene Amplification In RhabdomyosarcomaNational Cancer Institute2005–2009
- Studies Of The T(2;13) Of Alveolar RhabdomyosarcomaNational Cancer Institute2003–2007
- Cancer Molecular Pathology Training ProgramNational Cancer Institute2001–2006
- IRSG Studies Of Alveolar Rhabdomyosarcoma Gene FusionsNational Cancer Institute2001–2005
- Studies Of The T (2;13) Of Alveolar RhabdomyosarcomaNational Cancer Institute2001–2002
- Regulation Of Pax3/Pax7 Expression In RhabdomyosarcomaNational Cancer Institute1997–2001
- Studies Of The (2;13) Of Alveolar RhabdomyosarcomaNational Cancer Institute2000
- T(2--13) Of Alveolar RhabdomyosarcomaNational Cancer Institute1998–1999
- IRSG Laboratory Correlative StudiesNational Cancer Institute1998–1999
- Mechanisms Of Genomic Rearrangement In CarcinogenesisNational Cancer Institute1994–1998
- Alveolar RhabdomyosarcomaNational Cancer Institute1994–1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: